Cencora, Inc. COR
Rating
Rating Factors
Company Overview
Cencora, Inc. is a global pharmaceutical solutions organization that operates primarily within the healthcare distribution and services industry. Formerly known as AmerisourceBergen, the company rebranded to Cencora in 2023 to reflect its broader role beyond traditional drug distribution. Its core business centers on the distribution of pharmaceuticals, biotechnology products, and healthcare services to a wide range of providers, manufacturers, and patients.
The company’s primary revenue driver is pharmaceutical distribution, particularly in the U.S. healthcare market, where it serves retail pharmacies, hospital systems, physician practices, and long-term care facilities. Cencora is strategically positioned as one of the largest pharmaceutical distributors in North America, with scale, regulatory expertise, and supply chain infrastructure serving as key competitive advantages. Founded in 2001 through the merger of Bergen Brunswig and AmeriSource Health, the company expanded organically and through acquisitions, becoming a critical intermediary in the global pharmaceutical supply chain.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
Valuation
Dividends and Shares
Corporate Info
Conshohocken, PA 19428-1800